PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PDAC - PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged t cells take on Hard-to-Treat cancers
Disease control TEMPORARILY_NOT_AVAILABLEThis treatment program tests a personalized cell therapy for people with advanced pancreatic or colorectal cancers that have a specific genetic mutation (KRAS G12D). Patients' own immune cells are collected, genetically engineered to recognize and attack the cancer, and then infu…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New hope for pancreatic cancer: targeted drug enters final testing phase
Disease control OngoingThis phase 3 trial tests a new drug called daraxonrasib (RMC-6236) against standard treatments for people with metastatic pancreatic cancer that has already been treated. About 500 adults with a specific RAS gene mutation will be randomly assigned to receive either the new drug o…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Can enzyme pills help pancreatic cancer patients keep weight on?
Symptom relief OngoingThis study looks at whether a pancreatic enzyme pill (pancrelipase) can help people with advanced pancreatic cancer maintain or gain weight. The trial includes 17 participants who are starting chemotherapy and will receive either the enzyme or a placebo. The main goal is to see i…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 18, 2026 11:49 UTC
-
New MRI technique may forecast pancreatic cancer outcomes
Knowledge-focused TerminatedThis study explores whether a new type of MRI (6D-MRI) can predict how well pancreatic cancer patients respond to treatment. Researchers will scan 36 patients before and during chemotherapy to see if imaging features can forecast cancer progression or successful surgery. The stud…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:26 UTC